A landmark feasibility study has documented that all seven participants with chronic post-stroke arm weakness experienced safe and measurable improvements following epidural spinal cord stimulation treatment. The research, published in Nature Medicine, represents a significant finding given that approximately 30% of the 101 million global stroke survivors develop persistent arm weakness.
Participants demonstrated enhanced strength and motor function alongside reduced spasticity—common complications following stroke. The technique involves implanting electrodes on the cervical spinal cord to activate neural circuits controlling arm and hand movement. These results establish the safety foundation necessary for larger randomized controlled trials, which are essential before this intervention can be considered for broader clinical implementation.
Read the full article on GMJ Newsroom.
Was this article helpful?
